Pharmaceutical Technology11m
AbbVie’s Elahere wins European approval for certain ovarian cancers
The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.
Pharmaceutical Technology37m
FDA approves Syndax’s Revuforj to treat leukaemia
The US FDA has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating acute leukaemia with KMT2A translocation.